ArticleAnnals of medicine2025
Feasibility and safety of ipsilateral antegrade 4-French access in the endovascular treatment of peripheral artery disease.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTraditionally, contralateral retrograde or ipsilateral antegrade 6 F access has been the predominant approach for endovascular interventions in peripheral artery disease (PAD). This study explores the feasibility and safety of using ipsilateral antegrade 4 F access as an alternative in the endovascular treatment of PAD.
objectivesThe objective of this study is to evaluate the technical success and complication rates associated with ipsilateral antegrade 4 F access in PAD patients undergoing endovascular procedures. PATIENTS AND
methodsThis retrospective study included 113 PAD patients (77 males and 36 females) who underwent endovascular treatment using the ipsilateral antegrade 4 F technique between February 2020 and July 2023. Data on patient demographics, procedural characteristics, technical success, and periprocedural complications were collected and analyzed.
resultsComplete technical success was achieved in 106 cases (93.8%), partial technical success in 6 cases (5.3%), and technical failure in 1 case (0.9%). Complications occurred in 4 patients (3.5%), while 109 patients (96.5%) had no complications.
conclusionsIpsilateral antegrade 4 F access demonstrates high technical success and low complication rates, suggesting it is a viable and safe alternative for endovascular treatment of PAD. However, further prospective studies are recommended to validate these findings and to assess the long-term safety and effectiveness of this technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.